Literature DB >> 26064398

Cherubism misdiagnosed as giant cell tumor: a case report and review of literature.

Yang Jiao1, Mi Zhou1, Yaowu Yang2, Jun Zhou3, Xiaohong Duan1.   

Abstract

Cherubism is characterized by progressive, painless, bilateral enlargement of the mandible and/or maxilla resulting from the replacement of bone with multilocular cysts composed of fibrotic stromal cells and osteoclast-like cells. Here we report one Chinese cherubism case that has been misdiagnosed for more than forty years. The patient displayed no typical clinical or radiographical signs of cherubism due to multi-surgical treatments. Her histopathologic examination revealed the proliferating fibrous connective tissue with few multinucleated giant cells. The family history suggested us to perform sequence analysis of the SH3BP2 gene, a candidate marker for cherubism, in the family, and it was found that both the proband and the son had a missense mutation in SH3BP2 in exon 9 (p. Arg415Gln). Here we emphasize the importance of gene testing in the diagnosis of suspected cherubism, especially for those cases with non-typical clinical, radiographic and histological presentations.

Entities:  

Keywords:  Cherubism; SH3BP2; diagnosis

Year:  2015        PMID: 26064398      PMCID: PMC4443232     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

1.  Treatment of fibrous dysplasia of the mandible with radical excision and immediate reconstruction: case report.

Authors:  M R Zenn; J Zuniga
Journal:  J Craniofac Surg       Date:  2001-05       Impact factor: 1.046

2.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

3.  Cherubism - new hypotheses on pathogenesis and therapeutic consequences.

Authors:  Peter Hyckel; Alexander Berndt; Peter Schleier; Joachim H Clement; Volkmar Beensen; Hartmut Peters; Hartwig Kosmehl
Journal:  J Craniomaxillofac Surg       Date:  2005-01-12       Impact factor: 2.078

4.  Clinicopathologic study of 24 cases of cherubism.

Authors:  X-M Meng; S-F Yu; G-Y Yu
Journal:  Int J Oral Maxillofac Surg       Date:  2005-06       Impact factor: 2.789

Review 5.  The adapter 3BP2: how it plugs into leukocyte signaling.

Authors:  Marcel Deckert; Robert Rottapel
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

6.  Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.

Authors:  V M Carvalho; P F Perdigão; F R Amaral; P E A de Souza; L De Marco; R S Gomez
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

7.  Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.

Authors:  S M Bell; M Shaw; Y S Jou; R M Myers; M A Knowles
Journal:  Genomics       Date:  1997-09-01       Impact factor: 5.736

8.  Neurofibromatosis presenting with a cherubism phenotype.

Authors:  C I van Capelle; P H G Hogeman; C J M van der Sijs-Bos; B G F Heggelman; B Idowu; P J Slootweg; A R M Wittkampf; A M Flanagan
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

9.  A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.

Authors:  Yoshimichi Imai; Kiyoshi Kanno; Takuya Moriya; Shuji Kayano; Hiroto Seino; Yoichi Matsubara; Atsushi Yamada
Journal:  Cleft Palate Craniofac J       Date:  2003-11

10.  Non-familial cherubism.

Authors:  V Jain; S R Gamanagatti; A Gadodia; P Kataria; S S Bhatti
Journal:  Singapore Med J       Date:  2007-09       Impact factor: 1.858

View more
  1 in total

Review 1.  Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton.

Authors:  Salvatore Stefanelli; Pravin Mundada; Anne-Laure Rougemont; Vincent Lenoir; Paolo Scolozzi; Laura Merlini; Minerva Becker
Journal:  Insights Imaging       Date:  2018-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.